Laura Silva-Perez
Salamanca, CL, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Impact of CD44 alternative splicing on the response to anticancer drugs.
Journal: Biochemical pharmacology
Published: March 05, 2026
Role of tumor suppressor genes P53 and PTEN in CD44-mediated gastric adenocarcinoma multidrug resistance.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 13, 2025
Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 04, 2024
Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: April 09, 2024
Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma.
Journal: Cancers
Published: June 29, 2020
Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters.
Journal: Biochemical pharmacology
Published: August 27, 2019
What "The Cancer Genome Atlas" database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs.
Journal: Expert opinion on drug metabolism & toxicology
Published: June 12, 2019
MRP3-Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression.
Journal: Hepatology (Baltimore, Md.)
Published: May 31, 2019
Unraveling 'The Cancer Genome Atlas' information on the role of SLC transporters in anticancer drug uptake.
Journal: Expert review of clinical pharmacology
Published: February 13, 2019
Evaluation of the promiscuous component of several bacterial export pumps TolC as a biomarker for toxic pollutants in feedstuffs.
Journal: Chemico-biological interactions
Published: September 27, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026